HPS Pharmacies wish to give notice that AstraZeneca is discontinuing Bricanyl® ampoules as follows:

Bricanyl® Ampoules
Terbutaline sulfate 500 mcg/mL
ARTG 12068

Bricanyl® ampoules are set to be discontinued on 1 December 2026. Following this discontinuation, salbutamol will be the only injectable beta₂-agonist available in Australia.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact AstraZeneca on 1800 805 342 or your pharmacist at HPS Pharmacies.

Download PDF

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates